Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL152677)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (RO1 AR073270)
Article History
Received: 7 April 2023
Accepted: 10 June 2023
First Online: 8 July 2023
Change Date: 27 July 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13075-023-03123-6
Declarations
:
: Not applicable.
: Not applicable.
: MH is a member of an Advisory Board for Boehringer Ingelheim and has received consulting fees from ImmuneID. MH has received funding from Boehringer Ingelheim and Kadmon Pharmaceutical for investigator-initiated research proposals.JPHS and AM have no disclosures.